-
First, clarify thrombolytic and anticoagulant therapy for stroke caused by atrial fibrillation
Time of Update: 2023-02-03
*For medical professionals onlyThrombolytic and anticoagulant therapy for stroke caused by atrial fibrillationWritten by | Bi GuangyiCardioembolic stroke (CES), abbreviated as cardiogenic stroke, refe
-
It is advisable to use it as soon as possible! SGLT-2i can reduce the risk of "atrial fibrillation" in elderly diabetics
Time of Update: 2023-01-07
Recently, the first clinical practice survey study published in JAMA Network Open on the risk of atrial fibrillation (AF) in the treatment of elderly patients with type 2 diabetes mellitus with antidiabetic drugs SGLT2 inhibitors found that sodium glucose was used compared with dipeptidyl peptidase IV (DPP-4i) in elderly patients with type 2 diabetes The risk of AF with co-transporter-2 inhibitors (SGLT-2is) was significantly reduced by 18%.
-
2022 ESO Guidelines: "Screening for subclinical atrial fibrillation after unexplained ischemic stroke or transient ischemic attack" released
Time of Update: 2023-01-06
Question 3: For adult patients with unexplained ischaemic stroke or TIA, does an implantable monitoring device increase the detection rate of subclinical AF, improve anticoagulation rate, reduce recurrent stroke or systemic embolism, intracranial hemorrhage, any major bleeding, mortality compared with any non-implantable external monitoring device, And improved functional prognosis?
-
2022 ESO Guidelines: "Screening for subclinical atrial fibrillation after unexplained ischemic stroke or transient ischemic attack" released
Time of Update: 2023-01-06
Question 3: For adult patients with unexplained ischaemic stroke or TIA, does an implantable monitoring device increase the detection rate of subclinical AF, improve anticoagulation rate, reduce recurrent stroke or systemic embolism, intracranial hemorrhage, any major bleeding, mortality compared with any non-implantable external monitoring device, And improved functional prognosis?
-
European Radiology: Potential value of carotid CTA in predicting atrial fibrillation
Time of Update: 2023-01-04
In contrast, AS on the embolization tracking chart was not significantly associated with atrial fibrillation or elevated LAP.
In contrast, AS on the embolization tracking chart was not significantly associated with atrial fibrillation or elevated LAP.
-
JAMA sub-journal: Predictors of atrial fibrillation in stroke patients due to large/small vessel disease
Time of Update: 2023-01-04
The Known Cause Stroke and Underlying Atrial Fibrillation (STROKE AF) trial found that about one in eight patients with a recent ischemic stroke due to large/small vessel disease had atrial fibrillation (AF) after a stroke detected by a pluggable heart monitor (ICM) at 12 months.
-
Am J Med: Microvascular disease burden and atrial fibrillation risk in adults with type 2 diabetes
Time of Update: 2022-11-25
Conclusion: In adults with type 2 diabetes mellitus, the presence and burden of diabetic microvascular disease are independently correlated with the risk of developing atrial fibrillation.
In adults with type 2 diabetes mellitus, the presence and burden of diabetic microvascular disease are independently correlated with the risk of developing atrial fibrillation.
-
Med Princ Pract: risk factor for new-onset atrial fibrillation during thyroid surgery
Time of Update: 2022-11-25
Table 1 Features of patients with or without NOAFTable 2 Univariate logistic regression analysisTable 3 Multivariate logistic regression analysisConclusion: The incidence of NOAF in thyroid surgery is similar to other types of surgery in the setting of normal thyroid hormones.
-
Hypoglycemic nova has made new discoveries! SGLT-2i may help reduce the risk of "atrial fibrillation"
Time of Update: 2022-11-01
The latest research results show that sodium-glucose cotransporter-2 inhibitors (SGLT-2i) may be able to do this!Recently, the first clinical practice investigation on the risk of atrial fibrillation (AF) of the hypoglycemic drug SGLT-2i in the treatment of elderly patients with type 2 diabetes mellitus (T2D) published in JAMA Network Open found that in elderly T2D patients, compared with dipeptidyl peptidase 4 inhibitors (DPP-4i), the risk of AF after using SGLT-2i was significantly reduced, which is of important clinical guiding significance.
-
Diabetes care: "Prediabetes" may increase the risk of heart failure in people with atrial fibrillation!
Time of Update: 2022-11-01
Patients newly diagnosed with atrial fibrillation (AF) between 2015 and 2018 were compared into three groups (normoglycemia, prediabetes, and type 2 diabetes) based on baseline blood glucose status, and the primary finding was the occurrence of heart failure events.
-
Stroke: occult stroke is a risk factor for stroke recurrence in patients with atrial fibrillation
Time of Update: 2022-10-31
Regarding the one-year cumulative incidence of recurrent ischaemic stroke and all-cause death, the two groups were compared using the Fine and Gray subdistributed hazard model and the Cox frailty model with non-stroke death as a competitive risk, respectively.
-
Stroke: occult cerebral infarction is a risk factor for stroke recurrence in patients with atrial fibrillation
Time of Update: 2022-10-31
The investigators compared the cumulative one-year incidence of ischemic stroke recurrence and all-cause mortality between the two groups, using the Fine and Gray subdistribution risk models and the Cox frailty model with non-stroke death as a competitive risk, respectively.
-
Neuroreview Research advances in venous thrombolysis in acute ischemic stroke with atrial fibrillation
Time of Update: 2022-09-30
Atrial fibrillation is an independent risk factor for ischemic stroke, and studies have shown that atrial fibrillation increases the risk of ischemic stroke by a factor of 4 to 5 when other vascular r
-
Management of acute ischemic stroke during anticoagulation of atrial fibrillation
Time of Update: 2022-09-30
It's so divineFAST breaks the "taboo", and the 95-year-old man escapes from deathExamination items and timing of 10 complications of diabetes Acute ischemic stroke (CIS) has surpassed cardiovascular disease and malignant tumors in China and become the first cause of death.
-
Clin Res Cardiol: Heterogeneity of prognosis in patients with diabetes mellitus complicated with atrial fibrillation taking edoxaban
Time of Update: 2022-09-30
Clin Res Cardiol 2022 Aug 17 Background: In patients with atrial fibrillation (AF) who did not receive oral anticoagulation therapy (OAC), the presence of diabetes mellitus was associated with a higher incidence of thromboembolic events during follow-up, independent of other variables that affect cardiovascular risk.